As of 2026-03-23, the Relative Valuation of Selecta Biosciences Inc (SELB) is (2.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -327.9%.
The range of the Relative Valuation is (4.19) - 0.65 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 22.6x | 20.0x |
| Forward P/E multiples | 21.0x - 25.6x | 21.8x |
| Fair Price | (4.19) - 0.65 | (2.01) |
| Upside | -574.9% - -26.3% | -327.9% |
| Date | P/E |